An observational study in Inflammatory Rheumatism, 18-FDG and Positron-emission Tomography, sponsored by University Hospital, Brest. Not yet recruiting at 1 site in France. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2024-08-20.
Sponsored by University Hospital, Brest · Observational
Study of the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and comparaison with others inflammatories diseases.
Polymyalgia Rheumatica is difficult to diagnostic because symptoms are non specific and many diseases can be differential diagnosis (cancer, infections, others rheumatisms...).
PET-CT is more often used to help for diagnostic of inflammatory disease, and particularly inflammatory rheumatism.
Some scores have been described to harmonize the diagnosis of Polymyalgia rheumatica.
The aim of this study is to evaluate the diagnostic performance of 18-FDG PET scores in Polymyalgia rheumatica and compared with others inflammatories diseases such as ankylosing spondylarthritis.
This is a multicentric retrospective study.
55 studies on the registry are indexed under Rheumatic Fever; 21 are open to participants now.
This study's planned enrollment of 210 is below the median of 300 across 26 observational studies indexed under Rheumatic Fever.
Browse Rheumatic Fever studies →University Hospital, Brest is the lead sponsor of 601 studies on the registry; 136 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adult with inflammatory rheumatism confirmed by specialist, with or without treatment and having a 18-FDG-PET CT.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Diagnostic performance of 18-FDG PET scores for diagnostic of Polymyalgia rheumatica.
Evaluation of the metabolism of mains joints compared to liver. Calculation of different scores described in literature.
Time frame: up to 9 months
Analysis of SUV and visual fixation of mains joints.
Measure of SUV of mains joints and evaluation of the fixation compared to liver.
Time frame: up to 9 months
Diagnostic performance of 18-FDG PET scores for diagnostic of others inflammatory rheumatism.
Evaluation of the precedent scores for diagnosis of others rheumatisms. Creation of others scores if some joints seem to be interesting.
Time frame: up to 9 months
Comparaison of scores with clinical, biological and radiological data.
Search for correlation between scores and symptoms, blood test or CT/MRI exams.
Time frame: up to 9 months
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
Time frame: Data will be available beginning three years and ending fifteen years following the final study report completion
Access criteria: Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.